Figure 1.
Effect of cisplatin on cell viability. Different cells types (AD293-(a), Hela-(b), and OVCAR-3-(c)) were incubated with variant doses of cisplatin for 24 h. Cell viability was determined by MTT and Neutral Red assays. Data are mean ± SD; n = 6–8 wells for each group/cell type; ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001 versus control.